Transcat (NASDAQ:TRNS) Upgraded by StockNews.com to Hold Rating

StockNews.com upgraded shares of Transcat (NASDAQ:TRNS) from a sell rating to a hold rating in a report issued on Tuesday morning.

Several other research firms have also weighed in on TRNS. Craig Hallum lifted their price objective on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Oppenheimer reissued an “outperform” rating and issued a $130.00 price target (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. HC Wainwright reaffirmed a “buy” rating and set a $156.00 price objective on shares of Transcat in a research report on Tuesday, October 29th. Finally, Northland Securities dropped their target price on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a research report on Wednesday, October 30th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $130.25.

Transcat Price Performance

Shares of TRNS stock opened at $86.53 on Tuesday. The stock has a market capitalization of $795.99 million, a PE ratio of 43.70 and a beta of 0.71. The business’s 50 day simple moving average is $104.98 and its 200 day simple moving average is $115.11. Transcat has a one year low of $75.18 and a one year high of $147.12.

Transcat (NASDAQ:TRNS) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.63% and a return on equity of 7.36%. During the same period last year, the company posted $0.56 EPS. As a group, research analysts expect that Transcat will post 2.44 earnings per share for the current year.

Institutional Investors Weigh In On Transcat

Several hedge funds and other institutional investors have recently modified their holdings of the company. nVerses Capital LLC bought a new position in shares of Transcat in the third quarter valued at $60,000. US Bancorp DE lifted its position in Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after acquiring an additional 209 shares in the last quarter. Captrust Financial Advisors acquired a new position in Transcat during the 3rd quarter valued at about $201,000. SG Americas Securities LLC bought a new stake in Transcat during the 4th quarter worth approximately $182,000. Finally, Walleye Capital LLC bought a new stake in Transcat during the 3rd quarter worth approximately $216,000. Institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.